Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery

Author: Pinne Marija   Raucy Judy L  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.9, Iss.6, 2014-06, pp. : 669-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next